NAARI

NAARI aspires to be a world leader in the area of female healthcare, providing medical solutions from puberty to menopause. Our aim is to be the world’s first 100% integrated generic female health pharmaceutical company. This implies complete involvement in every step of production, going from plant extract to final dosage forms.

Naari AG is a Swiss pharma company focused on female hormones. We have two plants one is Kashipur which is API unit called Indo Phyto Chemicals Pvt. Ltd. (wholly owned subsidiary of Naari) and formulation unit is in Rudrapur. We have subsidiary & Front end marketing in CIS Countries , Russia , Ukraine that is headed by Mr. Manfred Paul.(Ex. M.D of Bayer). We have contract development partnership in Spain. For Diagnostic we have Contract Manufacturing in China (Approved by EU).

NAARI aspires to be a world leader in the area of female healthcare, providing medical solutions from puberty to menopause. Our aim is to be the world’s first 100% integrated generic female health pharmaceutical company. This implies complete involvement in every step of production, going from plant extract to final dosage forms.

NAARI aspires to be a world leader in the area of female healthcare, providing medical solutions from puberty to menopause. Our aim is to be the world’s first 100% integrated generic female health pharmaceutical company. This implies complete involvement in every step of production, going from plant extract to final dosage forms.

NAARI aspires to be a world leader in the area of female healthcare, providing medical solutions from puberty to menopause. Our aim is to be the world’s first 100% integrated generic female health pharmaceutical company. This implies complete involvement in every step of production, going from plant extract to final dosage forms. By giving our stake holders cutting edge expertise, we set the standard for female health products, globally.